Duration of anticoagulant therapy and VTE recurrence in patients with cancer

PURPOSE: Anticoagulant therapy for at least 3–6 months is currently recommended for treatment of venous thromboembolism (VTE) in patients with cancer, but the optimal duration of treatment is unknown. This study examines the association between the duration of anticoagulation treatment and VTE recur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Support Care Cancer
Autors principals: Khorana, Alok A., McCrae, Keith R., Milentijevic, Dejan, Fortier, Jonathan, Nelson, Winnie W., Laliberté, François, Crivera, Concetta, Lefebvre, Patrick, Schein, Jeff
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726708/
https://ncbi.nlm.nih.gov/pubmed/30734088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-4661-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars